Diagnostic value of MRI for posttreatment surveillance of early-stage (I-II) glottic larynx cancer

There is no uniformity across various guidelines in defining the modality and frequency of the follow-up, particularly regarding radiological imaging. The objective is to assess the diagnostic performance of magnetic resonance imaging (MRI)-based posttreatment surveillance for early-stage (I-II) glo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mose, Lucas (VerfasserIn) , Korkmaz, Emre (VerfasserIn) , Visini, Miranda (VerfasserIn) , Giger, Roland (VerfasserIn) , Schanne, Daniel Hendrik (VerfasserIn) , Elicin, Olgun (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 02 September 2025
In: Strahlentherapie und Onkologie
Year: 2025, Pages: ?
ISSN:1439-099X
DOI:10.1007/s00066-025-02460-6
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00066-025-02460-6
Volltext
Verfasserangaben:Lucas Mose, Emre Korkmaz, Miranda Visini, Roland Giger, Daniel Hendrik Schanne, Olgun Elicin
Beschreibung
Zusammenfassung:There is no uniformity across various guidelines in defining the modality and frequency of the follow-up, particularly regarding radiological imaging. The objective is to assess the diagnostic performance of magnetic resonance imaging (MRI)-based posttreatment surveillance for early-stage (I-II) glottic squamous cell carcinoma of the larynx.
Beschreibung:Gesehen am 12.02.2026
Beschreibung:Online Resource
ISSN:1439-099X
DOI:10.1007/s00066-025-02460-6